Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Medical Genetics

Signs and the Path to a Clear Diagnosis

At a Glance

Alpha-mannosidosis is diagnosed by matching symptoms such as hearing loss, repeated infections, developmental delay, and skeletal changes with enzyme testing and MAN2B1 gene testing. A urine or blood test for certain sugar chains can suggest the condition but cannot confirm it alone.

The journey to an alpha-mannosidosis diagnosis often starts with symptoms that, on their own, seem like common childhood hurdles. However, when these “puzzle pieces” are viewed together, they form a pattern that points toward a rare metabolic condition [1]. Understanding these signs and the specific tests needed for a diagnosis is the first step in moving from uncertainty to a clear plan of care.

Common Early Symptoms

Most babies with alpha-mannosidosis appear healthy at birth, and early hearing tests may even be normal [2]. Symptoms usually begin to emerge in infancy, childhood, or sometimes even into adulthood [2][3].

  • Hearing and Speech: One of the most common early symptoms is hearing impairment. This can be sensorineural (involving the inner ear or nerve) or conductive (caused by chronic middle-ear disease and frequent infections) [1][4]. This frequently leads to significant speech delays [5].
  • Recurrent Infections: Many experience frequent infections, particularly in the upper respiratory tract (like chronic ear infections or colds) [5][4]. This is often linked to the way the condition affects the immune system [6].
  • Developmental and Motor Delay: You may notice missed milestones like walking or sitting up later than expected. Over time, difficulties with coordination or balance (ataxia) may become more noticeable [7][8].
  • Physical Features: Doctors may look for “coarse” facial features, such as a prominent forehead or a flattened bridge of the nose. Other physical signs can include hernias (bulges in the groin or belly button area) and dysostosis multiplex, a specific pattern of skeletal changes visible on X-rays [9][4].

Distinguishing Alpha-Mannosidosis from “Mimics”

Alpha-mannosidosis is frequently confused with a group of similar conditions called Mucopolysaccharidoses (MPS), particularly MPS I (also known as Hurler or Scheie syndrome) [10][11].

Both conditions share features like skeletal changes, coarse facial features, and hearing loss. However, they are caused by different missing enzymes and lead to the buildup of different substances [10][11]. While MPS I involves the buildup of glycosaminoglycans (GAGs), alpha-mannosidosis involves mannose-rich oligosaccharides [11][10]. Distinguishing between them is critical because the treatments for each are very different [11].

The Diagnostic Checklist

Getting a definitive diagnosis requires a specific set of tests. Doctors use a combination of screening and confirmatory tools.

1. Screening: Oligosaccharide Testing

A doctor may start by testing urine or blood for mannose-rich oligosaccharides [1][12].

  • What it tells us: High levels suggest that the body isn’t breaking down these sugars correctly [13].
  • The limit: While a very useful red flag, this test is for screening only. It cannot provide a final diagnosis on its own because other rare conditions can sometimes cause similar results [13][14].

2. Confirmation: Enzyme Activity

A critical step for diagnosis is measuring the activity of the lysosomal alpha-mannosidase enzyme [1].

  • The Test: This is typically done using white blood cells (leukocytes) or skin cells (fibroblasts) [15][16].
  • The Result: The diagnosis is supported when enzyme activity is markedly deficient. The exact percentage depends on the laboratory assay and the tissue used [2][15].

3. Confirmation: Genetic Testing

To be absolutely certain, doctors perform genetic testing to look for mutations in the MAN2B1 gene [12].

  • Biallelic Variants: For confirmation, the test generally needs to identify two disease-causing mutations, one inherited from each parent (referred to as being in trans) [12].
  • Hidden Mutations: Sometimes, standard genetic tests might find only one mutation, or they might find a “variant of uncertain significance.” In these situations, specialists may need to run more advanced tests (like deletion/duplication testing) to find structural changes in the DNA or interpret complex results [12][17].

By combining these three pieces—clinical symptoms, markedly deficient enzyme activity, and genetic confirmation—your care team can provide an accurate diagnosis [1].

Common questions in this guide

What symptoms can suggest alpha-mannosidosis?
Alpha-mannosidosis can cause hearing loss, speech delay, recurrent infections, developmental or motor delay, coordination or balance problems, coarse facial features, hernias, and skeletal changes. Symptoms may begin in infancy, childhood, or sometimes adulthood, and not every person has every feature.
How is alpha-mannosidosis confirmed?
Doctors usually combine clinical findings with urine or blood oligosaccharide screening, alpha-mannosidase enzyme activity testing, and MAN2B1 gene testing. Markedly low enzyme activity together with two disease-causing variants inherited one from each parent can establish the diagnosis.
Can an oligosaccharide test diagnose alpha-mannosidosis by itself?
No. High levels of mannose-rich oligosaccharides can signal that sugar breakdown is abnormal, but other rare conditions can produce similar results. The finding must be followed by enzyme and genetic testing.
What does low alpha-mannosidase enzyme activity mean?
The enzyme test measures lysosomal alpha-mannosidase activity in white blood cells or skin cells. Markedly reduced activity supports alpha-mannosidosis, but the expected percentage depends on the laboratory method and the tissue tested.
What happens if genetic testing finds only one MAN2B1 change?
A single MAN2B1 change or a DNA change whose medical meaning is unclear may not explain the condition. A genetics specialist may recommend deletion or duplication testing, other structural-variant testing, and review of the result alongside enzyme activity and clinical findings.
How is alpha-mannosidosis different from MPS I?
Alpha-mannosidosis and MPS I can both cause skeletal changes, coarse facial features, and hearing loss, but they involve different enzyme problems and different substances accumulating in the body. MPS I involves glycosaminoglycans, while alpha-mannosidosis involves mannose-rich oligosaccharides, so accurate testing is important because treatments differ.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the symptoms, such as recurrent infections and hearing loss, how did you rule out more common conditions like MPS I?
  2. 2.Was the enzyme activity testing performed using leukocytes or fibroblasts, and what were the specific results?
  3. 3.If genetic testing only found one MAN2B1 variant or a variant of uncertain significance, what are the next steps to look for a hidden structural variant?
  4. 4.How do the urinary oligosaccharide levels compare to what is typically seen in alpha-mannosidosis, and how will we use this test to monitor them over time?
  5. 5.At what age should we begin regular screenings for specific skeletal issues like dysostosis multiplex?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Recognition of alpha-mannosidosis in paediatric and adult patients: Presentation of a diagnostic algorithm from an international working group.

    Guffon N, Tylki-Szymanska A, Borgwardt L, et al.

    Molecular genetics and metabolism 2019; (126(4)):470-474 doi:10.1016/j.ymgme.2019.01.024.

    PMID: 30792122
  2. 2

    Ultra-orphan lysosomal storage diseases: A cross-sectional quantitative analysis of the natural history of alpha-mannosidosis.

    Zielonka M, Garbade SF, Kölker S, et al.

    Journal of inherited metabolic disease 2019; (42(5)):975-983 doi:10.1002/jimd.12138.

    PMID: 31222755
  3. 3

    Delayed diagnosis and clinical course of alpha-mannosidosis: A retrospective study of 25 patients with varying severity.

    Nurse JH, Hennermann JB, Curiati MA, et al.

    Genetics in medicine open 2025; (3()):103465 doi:10.1016/j.gimo.2025.103465.

    PMID: 41334501
  4. 4

    Long-term outcome of patients with alpha-mannosidosis - A single center study.

    Lipiński P, Różdżyńska-Świątkowska A, Iwanicka-Pronicka K, et al.

    Molecular genetics and metabolism reports 2022; (30()):100826 doi:10.1016/j.ymgmr.2021.100826.

    PMID: 35242565
  5. 5

    Long-term clinical evaluation of patients with alpha-mannosidosis - A multicenter study.

    Köse E, Kasapkara ÇS, İnci A, et al.

    European journal of medical genetics 2024; (68()):104927 doi:10.1016/j.ejmg.2024.104927.

    PMID: 38382588
  6. 6

    Retrospective Study of Clinical and Genetic Profiles of Alpha-Mannosidosis Patients From the UAE.

    Saad AK, Al-Hammadi T, Al-Ameri S, et al.

    JIMD reports 2025; (66(2)):e70001 doi:10.1002/jmd2.70001.

    PMID: 39926434
  7. 7

    Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.

    Borgwardt L, Thuesen AM, Olsen KJ, et al.

    Journal of inherited metabolic disease 2015; (38(6)):1119-27 doi:10.1007/s10545-015-9862-4.

    PMID: 26016802
  8. 8

    Intellectual functioning in alpha-mannosidosis.

    Cathey SS, Sarasua SM, Simensen R, et al.

    JIMD reports 2019; (50(1)):44-49 doi:10.1002/jmd2.12073.

    PMID: 31741826
  9. 9

    Unveiling alpha-mannosidosis in Iraqi children: A series of clinically and genetically characterized cases with novel MAN2B1 variant.

    Al Tai MR, Saadi NW, Alothman MS, et al.

    Molecular genetics and metabolism reports 2026; (46()):101282 doi:10.1016/j.ymgmr.2025.101282.

    PMID: 41567994
  10. 10

    Mucopolysaccharidosis Type I and α-Mannosidosis-Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations.

    Venezia M, Vinci M, Colomba P, et al.

    Biomedicines 2025; (13(5)) doi:10.3390/biomedicines13051199.

    PMID: 40427026
  11. 11

    Hearing impairment as an early sign of alpha-mannosidosis in children with a mild phenotype: Report of seven new cases.

    Lehalle D, Colombo R, O'Grady M, et al.

    American journal of medical genetics. Part A 2019; (179(9)):1756-1763 doi:10.1002/ajmg.a.61273.

    PMID: 31241255
  12. 12

    An unusual diagnosis of alpha-mannosidosis with ocular anomalies: Behind the scenes of a hidden copy number variation.

    Uguen K, Redon S, Rouault K, et al.

    American journal of medical genetics. Part A 2024; (194(5)):e63532 doi:10.1002/ajmg.a.63532.

    PMID: 38192009
  13. 13

    Analysis of serum oligosaccharides by UPLC-MS/MS for diagnosis and treatment monitoring of patients with alpha-mannosidosis.

    Kubaski F, Cason A, Herbst ZAM, et al.

    Molecular genetics and metabolism 2025; (144(3)):109042 doi:10.1016/j.ymgme.2025.109042.

    PMID: 39908789
  14. 14

    UPLC-MS/MS Analysis of Urinary Free Oligosaccharides for Lysosomal Storage Diseases: Diagnosis and Potential Treatment Monitoring.

    Huang R, Cathey S, Pollard L, Wood T

    Clinical chemistry 2018; (64(12)):1772-1779 doi:10.1373/clinchem.2018.289645.

    PMID: 30201803
  15. 15

    Alpha-Mannosidosis in a 3.5-Year-Old Girl: A Case Report.

    Bonilla Fornes S, Mendez Perez MP, Torres Diaz M, et al.

    Clinical case reports 2026; (14(8)):e73276 doi:10.1002/ccr3.73276.

    PMID: 42553539
  16. 16

    Can velmanase alfa be the next widespread potential therapy for alpha-mannosidosis?

    Abdul Ghani S, Burney S, Ul Hussain H, et al.

    International journal of surgery (London, England) 2023; (109(9)):2882-2885 doi:10.1097/JS9.0000000000000528.

    PMID: 37352513
  17. 17

    α-mannosidosis diagnosis in Brazilian patients with MPS-like symptoms.

    Marins M, Curiati MA, Gomes CP, et al.

    Orphanet journal of rare diseases 2024; (19(1)):439 doi:10.1186/s13023-024-03419-z.

    PMID: 39593065

This page explains alpha-mannosidosis symptoms and diagnostic testing for informational purposes only and does not constitute medical advice. A metabolic or genetics specialist should interpret your specific results.

Get notified when new evidence is published on Alpha-mannosidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.